The concept of therapeutic cancer vaccines is based on the activation of the immune system
against tumor cells after the presentation of tumor antigens. Nanoparticles (NPs) have …

Development of safe and effective cancer vaccine formulation is a primary focus in the field
of cancer immunotherapy. The recognition of the crucial role of dendritic cells (DCs) in …

With emerging success in fighting off cancer, chronic infections, and autoimmune diseases,
immunotherapy has become a promising therapeutic approach compared to conventional …

Polymeric nano-and microparticles have recently been shown to possess significant
potential as drug delivery systems. In particular, the use of biodegradable polymeric …

Encapsulation of tumor-associated antigens in polymer nanoparticles (NP) is a promising
approach to enhance efficiency of antigen delivery for anti-tumor vaccines. Head and neck …

Targeted drug delivery can significantly influence the efficacy of a drug. In the past decades,
diverse drug-delivery technologies, including nano-and microparticles, co-crystals, and …

Vaccines have successfully eradicated a large number of diseases. However, some
infectious diseases (such as HIV, Chlamydia trachomatis or Bacillus anthracis) keep …

Targeting antigen to dendritic cells (DCs) is a powerful and novel strategy for vaccination.
Priming or loading DCs with antigen controls whether subsequent immunity will develop and …

Nanocarriers with various compositions and biological properties have been extensively
applied for in vitro/in vivo drug and gene delivery. The family of nanocarriers includes …

Nanoparticles represent a potent antigen presentation and delivery system to elicit an
optimal immune response by effector cells targeting tumor-associated antigens expressed …